GlobeNewswire by notified

LeddarTech to Showcase Critical Sensing and Perception Solutions Enabling ADAS and Autonomous Driving at CES Las Vegas 2022

Share

LeddarTech invites LiDAR manufacturers, Tier 1-2 suppliers, system integrators and automotive OEMs to discover the latest in ADAS and AD sensing and perception technologies at booth 7061 January 5-8 at CES

QUEBEC, Dec. 14, 2021 (GLOBE NEWSWIRE) -- LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce its participation at five CES Las Vegas locations, January 5-8 ’22. The LeddarTech Showcase location will demonstrate four new leading solutions that enable OEMs, Tier 1-2 suppliers, system integrators and LiDAR manufacturers to solve critical ADAS and AD sensing and perception challenges across the entire value chain of the automotive, mobility and off-road vehicle markets. In addition, LeddarTech will also be present at four other Ecosystem Partner locations.

Introducing the LeddarTech Showcase (Booth #7061, LVCC West Hall)

The theme of LeddarTech’s CES destination booth (#7061) is “Solving Critical Sensing and Perception Challenges in ADAS and AD.” The booth, located in the all-new LVCC West Hall, in the heart of the Transportation/Vehicle Technology section, will feature groundbreaking technologies and solutions.

LeddarTech welcomes CES delegates to see firsthand solutions that address critical issues facing customers:

  1. Uncover the benefits of raw data fusion with LeddarVision
    A comprehensive open sensor fusion and perception solution for automotive and off-road industrial vehicle ADAS and autonomous L2-L5 driving applications.

  2. Maximize LiDAR performance with LeddarSteer™ DBSD
    A scalable, adaptable and reliable solid-state, automotive-grade digital beam steering device (DBSD) for LiDAR manufacturers and vision system developers enhances range and resolution while optimizing costs and form factors.

  3. Explore a LiDAR development solution that reduces risk, costs and time, enabling faster time-to-market with the LiDAR XLRator
    A versatile LiDAR development platform and auto-grade reference design solution. The XLRator is powered by the LeddarEngine (SoC and signal processing software) and critical components from development collaborators, ams OSRAM, STMicroelectronics and TE First Sensor that enable LiDAR manufacturers and Tier 1-2s and system integrators to develop automotive-grade LiDAR sensors meeting the specific requirements of OEMs. The XLRator platform also integrates the LeddarSteer DBSD.

  4. View the benefits of the LeddarEcho™ simulation tool in reducing development time
    A SiL sensor simulation software application for ADAS/AD system developers and integrators that models various sensor architectures and components to develop optimal LiDAR designs and validate the resulting performance within specific application use cases.

Also, visit LeddarTech at their Ecosystem Partner locations:

dSPACE (Booth #3555, LVCC West Hall), a company whose solutions have accelerated the development of innovative vehicle technology for decades, will host LeddarTech in demonstrating the LeddarEcho high-precision simulation tools and models created to support and significantly accelerate the development and validation of LeddarEngine-based LiDAR sensors and related ADAS & AD systems.

The Canadian Automotive Parts and Manufacturers’ Association (APMA) (Booth #6367, LVCC West Hall) is Canada’s national association representing OEM producers of parts, equipment, tools, supplies and advanced technology services for the worldwide automotive industry. LeddarTech is a proud member of the association and a technical contributor in the autonomous vehicle initiative “Project Arrow.”

Gouvernement du Québec - Investissement Québec (Booth #51827, The Venetian Expo, 2nd floor, 201 Sands Avenue, Las Vegas) is the go-to partner for international businesses thinking of locating to Québec. They also support the efforts made by Québec companies to access and expand into innovative markets. LeddarTech is proud to be a delegate on its CES trade mission. The company will be highlighting its sensor solutions for ITS and mobility applications.

Set a meeting with LeddarTech at CES:

LeddarTech will have representatives from all divisions available. You are invited to pre-arrange a meeting HERE for product demonstrations, media interviews, industry analyst or investor discussions, enquire about joining the Leddar™ Ecosystem or learn about the incredible career opportunities available. The team will be there to greet you at the booth or meet with you –by appointment only– in the LeddarTech business lounge #W318 at LVCC West Hall – Level 3.

About LeddarTech

LeddarTech provides the most flexible, robust and accurate sensing technology for advanced driver assistance systems (ADAS) and autonomous driving (AD). LeddarTech enables customers to solve critical environmental sensing, fusion and perception challenges across the entire value chain. The company offers cost-effective, scalable solutions such as LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model with multi-sensor support for camera, radar and LiDAR configurations. LeddarTech supports LiDAR makers and Tier 1-2 automotive system integrators with LeddarSteer™, a digital beam steering device, and the LiDAR XLRator development solution for automotive-grade solid-state LiDAR based on the LeddarEngine™ and core components from global semiconductor partners. LeddarTech is responsible for several cutting-edge remote-sensing innovations, with over 100 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Product Management, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Aino Health AB (publ): Norberg & Partner Sustainable Group AB (publ) tecknar aktier i Aino Health AB (publ).25.1.2022 19:45:00 CET | Pressemelding

Detta pressmeddelande utgör inte ett offentligt uppköpserbjudande eller annars ett erbjudande om att förvärva aktier. Norberg & Partner Sustainable Group AB (publ)tecknar aktier i Aino Health AB (publ) och utlöser därmed budplikt. Norberg & Partner Sustainable Group AB (publ), org.nr 559268-0663 (”Norberg & Partner”) har idag tecknat 15 384 616 aktier i Aino Health AB (publ), org.nr 559063-5073 (”Aino Health”) till ett pris om 0,65 kronor per aktie. Efter förvärvet äger Norberg & Partner cirka 36,38 procent av aktierna och rösterna i Aino Health. Genom förvärvet utlöses budplikt, vilket innebär att Norberg & Partner är skyldig att offentliggöra ett budpliktsbud avseende resterande aktier i Aino Health inom fyra veckor från förvärvet, alternativt avyttra så många aktier så att aktieinnehavet representerar mindre än tre tiondelar av röstetalet för samtliga aktier i Aino Health. För ytterligare information, se Norberg & Partners hemsida. www.norbergpartner.se/ Kontaktperson: Jyrki Eklund,

Sword Group: 2021 Fourth Quarterly Results | Exceptional Profitability25.1.2022 19:15:00 CET | Press release

2021 Fourth Quarterly Results Consolidated Revenue: €59.7m Consolidated Growth: +31.8% Organic Growth: +21.9% EBITDA Margin: 15.0% RESULTS 4TH QUARTER 2021 Q4 (1) €m 2021 2020 Revenue 59.7 45.3 EBITDA 9.0 7.6 EBITDA Margin 15.0% 13.0% (1) non audited figures Organic growth on a like-for-like basis and at constant exchange rates: +21.9%. YEAR 2021 Consolidated Revenue: €214.6m Organic Growth: +21.5% EBITDA Margin: 13.6% ANALYSIS The Revenue for the Fourth Quarter of 2021 amounts to €59.7m in consolidated terms and to €55.2m without taking into account the acquisition of AiM, added to the perimeter on 1 July 2021. The EBITDA margin for the quarter amounts to 15.0% and organic growth to +21.9%. For 2021, the consolidated revenue amounts to €214.6m with an EBITDA margin of 13.6%. Organic growth for the year amounts to +21.5%. The Group established its 2021 Business Plan based on an organic growth hypothesis of 13%. Sword outperformed in terms of growth while maintaining and even exceeding

Aino Health AB (publ): The board of Aino Health resolves on a directed issue of shares to Norberg & Partner Sustainable Group AB (publ).25.1.2022 19:00:00 CET | Press release

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail. The board of Aino Health AB (publ), reg. number 559063-5073 (the “Company”) has today, based on the authorisationfrom the annual general meeting on 24th of May 2021, resolved on a directed issue of 15 384 616 shares with deviation from the shareholders’ pre-emption right.The issue is directed to Norberg & Partner Sustainable Group AB (publ) (”Norberg & Partner”) in order to secure the Company’s long-term financing in a time-and cost-efficient manner and entails an estimated capital injection of approximately SEK 10 million. The subscription price was, after negotiations with the subscriber, determined to SEK 0.65 per new share, which corresponds to the market value as assessed by the board. The reason for the deviation from the shareholders’ pre-emptive right is to secure the Company’s long-term financing in a time- and cost-efficient manner. The new shar

Aino Health AB (publ): Styrelsen i Aino Health AB (publ) beslutar om en riktad nyemission till Norberg & Partner Sustainable Group AB (publ).25.1.2022 19:00:00 CET | Pressemelding

Styrelsen i Aino Health AB (publ), org.nr 559063-5073 (”Bolaget”) har, med stöd av bemyndigandet från årsstämman den 24 maj 2021, idag beslutat att genomföra en riktad nyemission av 15 384616 aktier med avvikelse från aktieägarnas företrädesrätt. Nyemissionen är riktad till Norberg & Partner Sustainable Group AB (publ) (”Norberg & Partner”) i syfte att säkra Bolagets långsiktiga finansiering och medför ett förväntat kapitaltillskott om ca 10 miljoner kronor. Teckningskursen har efter förhandling med teckningsberättigade fastställts till 0,65 kronor per aktie, vilket motsvarar av styrelsen bedömt marknadsvärde. Skälet till avvikelsen från aktieägarnas företrädesrätt är att emissionslikviden ska användas i syfte att på ett snabbt och kostnadseffektivt sätt stärka Bolagets långsiktiga finansiering. Betalning för de nyemitterade aktierna sker genom kontant betalning. Antalet aktier i Bolaget ökar med 15 384 616 aktier, från 26 901 155 aktier till 42 285 771 aktier. Aktiekapitalet i Bolaget

EXTRAORDINARY GENERAL MEETING APPROVES INCREASE OF CONDITIONAL CAPITAL AND SIKA PROPOSES ELECTION OF GORDANA LANDEN TO THE BOARD OF DIRECTORS25.1.2022 18:00:00 CET | Press release

EXTRAORDINARY GENERAL MEETING APPROVES INCREASE OF CONDITIONAL CAPITAL AND SIKA PROPOSES ELECTION OF GORDANA LANDEN TO THE BOARD OF DIRECTORS At an Extraordinary General Meeting, Sika’s shareholders approved the increase of conditional capital. Sika recommends the election of Gordana Landento the Board of Directors at the next Annual General Meeting, to be held on April 12, 2022. On January 25, 2022, an Extraordinary General Meeting of Sika AG was held. Based on Ordinance 3 of the Federal Council on measures to prevent the spread of COVID-19, it was not possible for shareholders to physically attend the Extraordinary General Meeting. Instead, shareholders cast their votes through the independent proxy. The shareholders approved an increase to the existing conditional capital from CHF 155,893.20 (corresponding to 15,589,320 registered shares with a par value of CHF 0.01 each) to CHF 187,893.20 (corresponding to 18,789,320 registered shares with a par value of CHF 0.01 each). Shareholder

FutureDial Automation Solutions Process Over 231 Million Preowned Mobile Phones Worldwide25.1.2022 14:30:00 CET | Press release

Growing adoption of FutureDial’s robotics and automation software by Wireless Carriers, Third-Party Logistics Providers (3PLs) and Mobile Device Recyclers led to explosive volumes of preowned iPhones and Android Smartphones being processed for resale in 2021 SUNNYVALE, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- FutureDial Incorporated continued its commanding lead in providing mobile device processing solutions for Wireless Carriers, Mobile Device Buy-Back & Trade-In Companies, Mobile Phone Recyclers and Third-Party Logistics Providers (3PLs) during the year, announcing that its robotics and automation software solutions have been used by customers in the mobile supply chain to data clear, functionally test and grade a cumulative total of over 231.4 Million pre-owned Android smartphones and iPhones worldwide, for resale on secondary markets. Additionally, the total number of functional tests using FutureDial software and robotics for quality assurance performed on preowned iPhones and A

HMNC Brain Health Expands International Patent Portfolio with Two Stress-axis Related Substances for Major Depressive Disorder25.1.2022 14:30:00 CET | Press release

In-Licensing arrangement with the renowned Max Planck Society, extends patent protection for clinical research and strengthens Nelivabon and Cortibon developmental projects The Company has also established an office in the United States, furthering global expansion strategy MUNICH, Germany, Jan. 25, 2022 (GLOBE NEWSWIRE) -- HMNC Brain Health, (“HMNC” or the “company”), a clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced that it has expanded its international patent portfolio in the field of psychiatric therapy with two patent families claiming substances for treating stress-axis related Major Depressive Disorder. These license agreements are part of a broader collaboration with the renowned Max-Planck-Society, comprising biomarker patent claims and therapeutic patent claims covering markets in Europe, the U.S., and now Asia, in particular Japan. Utilizing a more personalized approach to discovering new drugs in psychi